je.st
news
Tag: details
TeliaSonera talks up Tele2 Norway remedies, gives no details
2015-01-16 12:17:00| Telecompaper Headlines
(Telecompaper) TeliaSonera has issued statements about the updated remedy package that it has submitted to the Norwegian Competition Authority regarding its acquisition of Tele2 Norway, but has not given any details. It said it would guarantee continued strong competition in the Norwegian mobile market. Robert Andersson, head of the Europe region at TeliaSonera, said it strongly believes in this acquisition and its ambition is to close the transaction in the first quarter of 2015.
Tags: details
norway
talks
remedies
ELFA Announcement details 10 equipment acquisition trends of 2015.
2015-01-14 14:31:10| Industrial Newsroom - All News for Today
To assist businesses in planning acquisition strategies, ELFA revealed its Top 10 Equipment Acquisition Trends for 2015 based on, according to ELFA President and CEO William G. Sutton, recent research data distilled from 2015 Equipment Leasing & Finance U.S. Economic Outlook Report, industry participants’ expertise, and member input from ELFA meetings and conferences. Businesses are expected to find opportunities presented by steadily improving economy and favorable credit conditions.
Tags: details
equipment
trends
acquisition
Cutting through the details: My thoughts on Monday's USDA data dump
2015-01-09 23:07:00| Corn & Soybean Digest
Moral of the story, don't overthink this market and do not get overly convicted to your preconceived ideas or thoughts. This is simply about reducing your risk and turning a profit. The easier you can accomplish this goal the better your going to be. Grain Market Viewpoint read more
Tags: data
details
thoughts
cutting
New Orion Brochure Details Carbon Black Pigments for Tinting Applications
2015-01-09 06:00:00| Coatings World Breaking News
Tags: details
black
applications
carbon
Pfizer, FDA in talks on prescription details for key breast cancer drug
2015-01-08 18:21:28| Biotech - Topix.net
Pfizer Inc said Thursday it has begun talks with the U.S. Food and Drug Administration to finalize the prescription label of its breast cancer drug palbociclib, in an indication the drug was likely closer to regulatory approval. The largest U.S. drugmaker also said there was no plan for the agency to hold an advisory committee meeting to discuss the medicine prior to an approval decision.
Sites : [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] next »